Cancer News and Research

Latest Cancer News and Research

Broccoli blocks joint destruction in osteoarthritis: Research

Scientists at the University of East Anglia (UEA) are launching a groundbreaking new project to investigate the benefits of broccoli in the fight against osteoarthritis.Initial laboratory research at UEA has found that a compound in broccoli called sulforaphane blocks the enzymes that cause joint destruction in osteoarthritis the most common form of arthritis.

15 Sep 2010

Medical students should learn about economic forces that affect health care: JAMA

Medical students and residents should receive much more thorough and realistic instruction about the economic forces affecting health care and their own clinical decisions so that they can better serve patients' well-being and the nation's economic welfare, says a commentary published today in a theme issue of the Journal of the American Medical Association, which focuses on improving medical education.

15 Sep 2010

Phase II clinical trial shows GTx-758 reduces serum free testosterone

GTx, Inc. today announced that in a Phase II, open label, pharmacokinetic-pharmacodynamic clinical trial, GTx-758, an oral selective estrogen receptor alpha agonist being developed to treat advanced prostate cancer, suppressed serum total testosterone to castrate levels, increased serum SHBG (sex hormone binding globulin), and markedly reduced serum free testosterone in healthy male volunteers.

15 Sep 2010

Organizations issue five-point plan to accelerate research, discovery of effective prostate cancer treatments

With $3 billion spent on the over-treatment of prostate cancer each year, new discoveries are prompting the prostate cancer community to Advance on Washington the week of September 13 - 18. This initiative calls for renewed commitments to finding answers that will enable physicians to cure more and over-treat less. The nation's leading prostate cancer organizations today issued a five point plan, targeted to policymakers, to accelerate research and discovery of effective prostate cancer treatments.

15 Sep 2010

Flora Skeates represents Cancer Research UK in photographic exhibition at Oxo Tower

Mum-of-two Flora Skeates says she owes her life to cancer research after surviving bowel cancer twice within two years. That is why she is representing Cancer Research UK in a stunning new photographic exhibition to encourage people to remember the charity in their Will.

15 Sep 2010

COTI selected for Canadian life sciences partnering mission

Critical Outcome Technologies Inc. announced today that the Company was selected by the Consulate General of Canada and BIOTECanada to attend a life sciences partnering mission in Boston, MA. This initiative is being held in conjunction with the BioPharm America conference taking place September 15-17, 2010.

15 Sep 2010

Smoking cessation offers favorable economic benefits to California

A new study released today by the American Lung Association, and conducted by researchers at Penn State University, finds that helping smokers quit not only saves lives but also offers favorable economic benefits to California and the nation.

15 Sep 2010

TNS NIPO study underlines need for wide-scale, reliable prostate cancer screening

A recent TNS NIPO survey, on behalf of the Dutch Association of Urology (NVU) and the European Association of Urology (EAU), showed that almost four out of 10 Dutch men of 50 years and older suffer, or have suffered, from urinary complaints. The same number of men also said in the same survey they are worried that they may have prostate cancer.

15 Sep 2010

HHS awards $31 million as part of 'Communities Putting Prevention to Work' program

The U.S. Department of Health and Human Services (HHS) today announced $31 million for awards to ten communities in eight states and one award to a state health department to support public health efforts to reduce obesity and smoking, increase physical activity and improve nutrition.

15 Sep 2010

Study reveals men less likely to use active sun-protective measures

There is a significant disparity between knowledge and attitudes on the dangers of skin cancer among male and female medical students in Florida according to a new study by a joint team of researchers from Ben-Gurion University of the Negev and the University of Miami Miller School of Medicine. The study was published in the American Medical Association's Archives of Dermatology.

15 Sep 2010

Omnicell's medication management systems selected by Sentara Healthcare

Omnicell, Inc., a leading provider of system solutions to acute healthcare facilities, today announced that Sentara Healthcare has selected Omnicell OmniRx® automated medication dispensing systems and Omnicell's SecureVault™ to monitor and streamline medication management throughout its facilities. Sentara serves a patient population of more than two million, and chose to replace its current vendor with Omnicell for its solution reliability and customer service.

From Omnicell, Inc. 15 Sep 2010

PAF announces expansion of Colorectal Care Line

The Patient Advocate Foundation (PAF), a national non-profit resolving patient access to health care issues, medical financial limitations, insurance denials and multiple government program enrollments, including Medicaid and Social Security Disability Income announced today a significant expansion of its Colorectal Care Line (CCL), beginning September 13, 2010.

15 Sep 2010

Healthy lifestyle pattern reduces mortality

It is widely known that a healthy lifestyle that includes not smoking, limiting alcohol intake, and maintaining a proper weight reduces disease risk.

15 Sep 2010

Survey reveals inadequate provision for women with secondary breast cancer

57% of breast care nurses who took part in a UK survey for the charity Breast Cancer Care feel that there is inadequate provision for women with secondary breast cancer, a progressive incurable disease that kills half a million women worldwide every year after the cancer spreads to other organs. Many said that they felt ill equipped to care for women with secondary breast cancer and that their time was dominated by meeting the needs of women with primary breast cancer.

15 Sep 2010

ADVENTRX announces Exelbine 12-month stability test results

ADVENTRX Pharmaceuticals, Inc. today announced the results of stability tests performed on samples of ANX-530 (vinorelbine injectable emulsion), or Exelbine™, manufactured at the Company's intended commercial manufacturing site.

15 Sep 2010

Pancreatic Cancer Action Network launches campaign to increase disease awareness

Lisa Niemi Swayze joins the Pancreatic Cancer Action Network to launch "Be a Hero in the Fight Against Pancreatic Cancer: Know it. Fight it. End it." campaign to increase awareness of the deadly disease that claimed the life of her husband, actor Patrick Swayze, one year ago.

15 Sep 2010

AAPCHO launches campaign to raise chronic hepatitis B awareness

The U.S. Department of Health and Human Services' Office of Minority Health, the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations (AAPCHO) today launched a new campaign to raise awareness of the epidemic of chronic hepatitis B among Americans of Asian and Pacific Islander heritage.

15 Sep 2010

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

On Thursday, Sept. 16, the Stanford Cancer Center will become the first treatment center on the West Coast and the fifth in the world to offer cancer patients the TrueBeam, a machine that represents an exponential leap forward in the speed, power and precision of radiation therapy.

15 Sep 2010

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the PATH Malaria Vaccine Initiative (MVI) has agreed to provide follow-on funding to continue evaluation and development of Inovio's malaria DNA vaccine candidate in non-human primates.

15 Sep 2010

Compandia is now CompanDX

Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.

15 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Broccoli blocks joint destruction in osteoarthritis: Research

Medical students should learn about economic forces that affect health care: JAMA

Phase II clinical trial shows GTx-758 reduces serum free testosterone

Organizations issue five-point plan to accelerate research, discovery of effective prostate cancer treatments

Flora Skeates represents Cancer Research UK in photographic exhibition at Oxo Tower

COTI selected for Canadian life sciences partnering mission

Smoking cessation offers favorable economic benefits to California

TNS NIPO study underlines need for wide-scale, reliable prostate cancer screening

HHS awards $31 million as part of 'Communities Putting Prevention to Work' program

Study reveals men less likely to use active sun-protective measures

Omnicell's medication management systems selected by Sentara Healthcare

PAF announces expansion of Colorectal Care Line

Healthy lifestyle pattern reduces mortality

Survey reveals inadequate provision for women with secondary breast cancer

ADVENTRX announces Exelbine 12-month stability test results

Pancreatic Cancer Action Network launches campaign to increase disease awareness

AAPCHO launches campaign to raise chronic hepatitis B awareness

Stanford Cancer Center to use TrueBeam radiation therapy technology for cancer patients

MVI agrees to provide fund for evaluating Inovio's malaria DNA vaccine candidate in non-human primates

Compandia is now CompanDX

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in